139 related articles for article (PubMed ID: 3453720)
1. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis].
Hébert J; Bédard PM
Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720
[TBL] [Abstract][Full Text] [Related]
2. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
4. Hyposensitization in hay fever with grass pollen extracts: a three-year study comparing a dialysed alum adsorbed extract with allpyral.
Haahtela T; Wihl JA; Munch E; Vilkka V; Hagelund CH; Watson HK
Ann Allergy; 1984 May; 52(5):355-62. PubMed ID: 6721260
[TBL] [Abstract][Full Text] [Related]
5. [Hyposensitization with cross-reacting pollen allergens].
Karl S; Rakoski J
Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627
[TBL] [Abstract][Full Text] [Related]
6. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
8. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
10. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
12. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
Paranos S; Petrović S; Vojović I
Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
14. [Glutarladehyde-pollen-tyrosine hyposensitization. Course control of therapy using RIST and RAST].
Jarisch R
Hautarzt; 1977 Apr; 28(4):185-7. PubMed ID: 406220
[TBL] [Abstract][Full Text] [Related]
15. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
18. Rush immunotherapy with sublingual administration of grass allergen extract.
Feliziani V; Marfisi RM; Parmiani S
Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
20. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
Senna GE; Andri G; Dama AR; Falagiani P; Andri L
Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
